Complement C1s-IN-1
Complement C1s-IN-1 is a potent, selective, orally active and cross the blood-brain barrier C1s inhibitor with an IC50 value of 36 nM[1].
Product Specifications
CAS Number
[3033831-40-9]
UNSPSC
12352005
Target
Complement System
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/complement-c1s-in-1.html
Purity
97.77
Solubility
10 mM in DMSO
Smiles
NC1=C(C(F)=CC(N2C[C@H](C3=NOC(C)=C3)N(C4=CC(F)=CC=C4)CC2)=C5)C5=CN=N1
Molecular Formula
C22H20F2N6O
Molecular Weight
422.43
References & Citations
[1]Ikeda Z, et al. Discovery of a Novel Series of Potent, Selective, Orally Available, and Brain-Penetrable C1s Inhibitors for Modulation of the Complement Pathway. J Med Chem. 2023 Apr 25.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1363267-01 0.02 mg (E-Coli)
Recombinant Bordetella pertussis Lipoyl synthase (lipA)
Ask
View Details MBS1363267-02 0.02 mg (Yeast)
Recombinant Bordetella pertussis Lipoyl synthase (lipA)
Ask
View Details 
MBS1363267-03 0.1 mg (E-Coli)
Recombinant Bordetella pertussis Lipoyl synthase (lipA)
Ask
View Details MBS1363267-04 0.1 mg (Yeast)
Recombinant Bordetella pertussis Lipoyl synthase (lipA)
Ask
View Details MBS1363267-05 0.02 mg (Baculovirus)
Recombinant Bordetella pertussis Lipoyl synthase (lipA)
Ask
View Details 
MBS1363267-06 0.02 mg (Mammalian-Cell)
Recombinant Bordetella pertussis Lipoyl synthase (lipA)
Ask
View Details